Search Browse Earnings

Societal CDMO, Inc. — SlamSEC

Societal CDMO, Inc.

Pharmaceutical Preparations·EXTON, PA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$75.4M

+13.3% YoY

FY 2023

Adj. EBITDA

$8.0M

10.6% margin

FY 2023

Net Income

-$11.4M

-15.1% margin

FY 2023

EPS (Diluted)

-$0.26

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$15.0M

FY 2023

Total Debt

$31.0M

FY 2023

Net Debt

$16.0M

FY 2023

Enterprise Value

—

Debt / EBITDA

2.0x

FY 2023

EV / EBITDA

—

Employees

—

CEO

Enloe J David Jr

CFO

Lake Ryan David